A new bill backed by Sen. Jon Husted would ban SNAP recipients from buying soda, candy and desserts, but public health ...

Inconspicuous, brown seeds that are easy to overlook on the health food shelf, yet flaxseed is one of the most powerful ...

An investigation by The Imprint reveals overmedication and spotty enforcement of federal requirements that child welfare ...

Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically ...

Both indications are genetically driven. An approval of Imcivree in hypothalamic obesity would be the first for this drug in an acquired form of obesity. It could also potentially become the first ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on curbing government spending.

India’s pharmaceutical market grew 8.4% in FY25, led by strong value growth in cardiac, gastrointestinal, and anti-diabetic therapies, according to Pharmarack.

Rhythm Pharmaceuticals (NASDAQ:RYTM) announced Monday that its lead asset, setmelanotide, reached the main goal in a pivotal Phase 3 trial against acquired hypothalamic obesity, a rare form of ...

Austria to ban mobile phones and smartwatches in primary and secondary schools on May 1 - Brazil enforces mobile phone ban in ...